PT941100E - Composicoes farmaceuticas - Google Patents

Composicoes farmaceuticas

Info

Publication number
PT941100E
PT941100E PT97950036T PT97950036T PT941100E PT 941100 E PT941100 E PT 941100E PT 97950036 T PT97950036 T PT 97950036T PT 97950036 T PT97950036 T PT 97950036T PT 941100 E PT941100 E PT 941100E
Authority
PT
Portugal
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
PT97950036T
Other languages
English (en)
Inventor
Gary Wayne Goodson
Allen Wayne Wood
Katherine Jeannette Ford
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PT941100E publication Critical patent/PT941100E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PT97950036T 1996-10-31 1997-10-29 Composicoes farmaceuticas PT941100E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9622681.6A GB9622681D0 (en) 1996-10-31 1996-10-31 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
PT941100E true PT941100E (pt) 2003-10-31

Family

ID=10802224

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97950036T PT941100E (pt) 1996-10-31 1997-10-29 Composicoes farmaceuticas

Country Status (44)

Country Link
EP (1) EP0941100B1 (pt)
JP (1) JP2001502718A (pt)
KR (1) KR100551652B1 (pt)
AP (1) AP1067A (pt)
AR (1) AR009135A1 (pt)
AT (1) ATE241364T1 (pt)
AU (1) AU736607B2 (pt)
BG (1) BG64541B1 (pt)
BR (1) BR9712614A (pt)
CA (1) CA2270174A1 (pt)
CO (1) CO4930269A1 (pt)
CY (1) CY2485B1 (pt)
CZ (1) CZ296080B6 (pt)
DE (1) DE69722433T2 (pt)
DK (1) DK0941100T3 (pt)
EA (1) EA002437B1 (pt)
EE (1) EE03806B1 (pt)
ES (1) ES2200204T3 (pt)
GB (1) GB9622681D0 (pt)
GE (1) GEP20022735B (pt)
GT (1) GT199700116A (pt)
HK (1) HK1020880A1 (pt)
HR (1) HRP970569B1 (pt)
HU (1) HU224969B1 (pt)
ID (1) ID18698A (pt)
IL (1) IL129422A0 (pt)
IS (1) IS5024A (pt)
MY (1) MY119513A (pt)
NO (1) NO317163B1 (pt)
NZ (1) NZ335153A (pt)
OA (1) OA11038A (pt)
PA (1) PA8441101A1 (pt)
PE (1) PE10099A1 (pt)
PL (1) PL190349B1 (pt)
PT (1) PT941100E (pt)
SI (1) SI0941100T1 (pt)
SK (1) SK284286B6 (pt)
SV (1) SV1997000090A (pt)
TR (1) TR199900950T2 (pt)
UA (1) UA64725C2 (pt)
UY (1) UY24766A1 (pt)
WO (1) WO1998018477A2 (pt)
YU (1) YU19999A (pt)
ZA (1) ZA979726B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
HUP0500217A2 (hu) * 2002-04-23 2005-06-28 Lupin Limited Tartós hatású, módosított hatóanyag-leadású mátrix készítmények
US20050287177A1 (en) * 2002-11-08 2005-12-29 Glaxo Group Unlimited And Smithkline Beecham Corp. Pharmaceutical compositions
NZ540728A (en) 2003-01-14 2008-08-29 Gilead Sciences Inc Compositions and methods for combination antiviral therapy
AR045841A1 (es) * 2004-09-28 2005-11-16 Richmond Sa Com Ind Y Financie Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r*, 8r*, 10r*,11r*)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla.
CN104203275A (zh) 2010-06-09 2014-12-10 疫苗技术股份有限公司 用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
RU2014140177A (ru) 2012-03-05 2016-04-27 Сипла Лимитед Фармацевтические антиретровирусные композиции
WO2014130553A2 (en) * 2013-02-20 2014-08-28 Abbvie Inc. Tablet dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
GB9110624D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Combinations
ATE131730T1 (de) * 1991-05-16 1996-01-15 Glaxo Group Ltd Nukleosidanalogen enthaltende antiviren- zubereitungen
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
DK0941100T3 (da) 2003-09-01
BG64541B1 (bg) 2005-07-29
EP0941100B1 (en) 2003-05-28
PL333143A1 (en) 1999-11-22
HUP0000344A3 (en) 2002-04-29
YU19999A (sh) 2000-10-30
DE69722433T2 (de) 2004-04-08
PL190349B1 (pl) 2005-11-30
ZA979726B (en) 1999-04-29
GB9622681D0 (en) 1997-01-08
EA002437B1 (ru) 2002-04-25
CZ296080B6 (cs) 2006-01-11
CO4930269A1 (es) 2000-06-27
AU736607B2 (en) 2001-08-02
NO317163B1 (no) 2004-08-30
BR9712614A (pt) 1999-10-26
OA11038A (en) 2002-02-06
CA2270174A1 (en) 1998-05-07
HUP0000344A2 (hu) 2001-05-28
KR100551652B1 (ko) 2006-02-13
EA199900345A1 (ru) 2000-02-28
UY24766A1 (es) 2000-12-29
ATE241364T1 (de) 2003-06-15
WO1998018477A3 (en) 1998-06-18
SV1997000090A (es) 1998-10-07
NZ335153A (en) 2001-04-27
TR199900950T2 (xx) 1999-07-21
UA64725C2 (uk) 2004-03-15
PA8441101A1 (es) 2000-05-24
MY119513A (en) 2005-06-30
IL129422A0 (en) 2000-02-17
SI0941100T1 (en) 2003-12-31
EE03806B1 (et) 2002-08-15
SK57599A3 (en) 2000-06-12
CZ155799A3 (cs) 1999-10-13
KR20000052893A (ko) 2000-08-25
GT199700116A (es) 1999-04-22
NO992091D0 (no) 1999-04-29
WO1998018477A2 (en) 1998-05-07
IS5024A (is) 1999-04-09
HU224969B1 (en) 2006-04-28
GEP20022735B (en) 2002-07-25
HRP970569B1 (en) 2004-10-31
HRP970569A2 (en) 1998-08-31
ID18698A (id) 1998-04-30
AR009135A1 (es) 2000-03-08
AU5314298A (en) 1998-05-22
HK1020880A1 (en) 2000-05-26
BG103435A (en) 2000-04-28
EP0941100A2 (en) 1999-09-15
AP9901519A0 (en) 1999-06-30
EE9900175A (et) 1999-12-15
JP2001502718A (ja) 2001-02-27
PE10099A1 (es) 1999-03-02
AP1067A (en) 2002-05-01
DE69722433D1 (de) 2003-07-03
CY2485B1 (en) 2005-06-03
NO992091L (no) 1999-06-29
ES2200204T3 (es) 2004-03-01
SK284286B6 (sk) 2005-01-03

Similar Documents

Publication Publication Date Title
ID18352A (id) Komposisi-komposisi farmasi
IS4706A (is) Lyfjasamsetningar
DK0938345T3 (da) Vandbaseret farmaceutisk sammensætning
EA199900373A3 (ru) Фармацевтические композиции
DE69708866D1 (de) Mikroverkapselte zusammensetzungen
DE69719442D1 (de) Frisierschaum-Zusammensetzungen
DE69733072D1 (de) Farbschonende zusammensetzungen
ID16781A (id) Formulasi-formulasi farmasi
EE9900260A (et) Ravimkompositsioonid külmkuivatamiseks
PT969815E (pt) Composicoes farmaceuticas
BR9507768A (pt) Composição farmacêutica
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
PT941100E (pt) Composicoes farmaceuticas
EE200000330A (et) Farmatseutilised kompositsioonid
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
EE200000459A (et) Farmatseutilised kompositsioonid
ITMI962628A0 (it) Composizione farmaceutica
FI962738A0 (fi) Farmaseuttiset koostumukset
NO994436D0 (no) Farmasöytiske sammensetninger
SE9601854D0 (sv) Farmaceutisk komposition
ID17133A (id) Komposisi farmasi
SE9604299D0 (sv) Pharmaceutical composition
ID21960A (id) Komposisi-komposisi hidrofluorokarbon
BR1100755A (pt) composição farmacêutica
KR960016881A (ko) 제약 조성물